UniProt ID | NTAL_HUMAN | |
---|---|---|
UniProt AC | Q9GZY6 | |
Protein Name | Linker for activation of T-cells family member 2 | |
Gene Name | LAT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 243 | |
Subcellular Localization |
Cell membrane Single-pass type III membrane protein . Present in lipid rafts. |
|
Protein Description | Involved in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. May also be involved in BCR (B-cell antigen receptor)-mediated signaling in B-cells and FCGR1 (high affinity immunoglobulin gamma Fc receptor I)-mediated signaling in myeloid cells. Couples activation of these receptors and their associated kinases with distal intracellular events through the recruitment of GRB2.. | |
Protein Sequence | MSSGTELLWPGAALLVLLGVAASLCVRCSRPGAKRSEKIYQQRSLREDQQSFTGSRTYSLVGQAWPGPLADMAPTRKDKLLQFYPSLEDPASSRYQNFSKGSRHGSEEAYIDPIAMEYYNWGRFSKPPEDDDANSYENVLICKQKTTETGAQQEGIGGLCRGDLSLSLALKTGPTSGLCPSASPEEDEESEDYQNSASIHQWRESRKVMGQLQREASPGPVGSPDEEDGEPDYVNGEVAATEA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
23 | Phosphorylation | VLLGVAASLCVRCSR HHHHHHHHHHHHCCC | 16.74 | 24719451 | |
25 | S-palmitoylation | LGVAASLCVRCSRPG HHHHHHHHHHCCCCC | 1.35 | 12486104 | |
28 | S-palmitoylation | AASLCVRCSRPGAKR HHHHHHHCCCCCCCH | 1.70 | 12486104 | |
38 | Ubiquitination | PGAKRSEKIYQQRSL CCCCHHHHHHHHHCH | 48.21 | 25015289 | |
40 | Phosphorylation | AKRSEKIYQQRSLRE CCHHHHHHHHHCHHH | 15.06 | 17993265 | |
44 | Phosphorylation | EKIYQQRSLREDQQS HHHHHHHCHHHHHHH | 27.69 | 23401153 | |
51 | Phosphorylation | SLREDQQSFTGSRTY CHHHHHHHHHCCCEE | 21.10 | 23401153 | |
53 | Phosphorylation | REDQQSFTGSRTYSL HHHHHHHHCCCEEEE | 39.22 | 30266825 | |
55 | Phosphorylation | DQQSFTGSRTYSLVG HHHHHHCCCEEEECC | 20.56 | 28450419 | |
57 | Phosphorylation | QSFTGSRTYSLVGQA HHHHCCCEEEECCEE | 21.11 | 28450419 | |
58 | Phosphorylation | SFTGSRTYSLVGQAW HHHCCCEEEECCEEC | 10.01 | 17993265 | |
59 | Phosphorylation | FTGSRTYSLVGQAWP HHCCCEEEECCEECC | 18.90 | 23401153 | |
77 | Ubiquitination | ADMAPTRKDKLLQFY HHCCCCCHHHHHHHC | 62.79 | 23000965 | |
77 (in isoform 2) | Ubiquitination | - | 62.79 | 21890473 | |
77 (in isoform 1) | Ubiquitination | - | 62.79 | 21890473 | |
79 | Ubiquitination | MAPTRKDKLLQFYPS CCCCCHHHHHHHCCC | 54.88 | 23000965 | |
79 (in isoform 2) | Ubiquitination | - | 54.88 | 21890473 | |
79 (in isoform 1) | Ubiquitination | - | 54.88 | 21890473 | |
84 | Phosphorylation | KDKLLQFYPSLEDPA HHHHHHHCCCCCCCC | 4.48 | 29978859 | |
86 | Phosphorylation | KLLQFYPSLEDPASS HHHHHCCCCCCCCHH | 32.77 | 23401153 | |
92 | Phosphorylation | PSLEDPASSRYQNFS CCCCCCCHHHCCCCC | 22.27 | 29523821 | |
93 | Phosphorylation | SLEDPASSRYQNFSK CCCCCCHHHCCCCCC | 36.79 | 29523821 | |
95 | Phosphorylation | EDPASSRYQNFSKGS CCCCHHHCCCCCCCC | 15.12 | 17993265 | |
99 | Phosphorylation | SSRYQNFSKGSRHGS HHHCCCCCCCCCCCC | 43.59 | 24719451 | |
100 | Ubiquitination | SRYQNFSKGSRHGSE HHCCCCCCCCCCCCC | 57.69 | 25015289 | |
102 | Phosphorylation | YQNFSKGSRHGSEEA CCCCCCCCCCCCCCC | 25.49 | 28188228 | |
106 | Phosphorylation | SKGSRHGSEEAYIDP CCCCCCCCCCCCCCH | 26.58 | 23401153 | |
110 | Phosphorylation | RHGSEEAYIDPIAME CCCCCCCCCCHHHHH | 14.77 | 28450419 | |
118 | Phosphorylation | IDPIAMEYYNWGRFS CCHHHHHHHCCCCCC | 6.76 | 30576142 | |
119 | Phosphorylation | DPIAMEYYNWGRFSK CHHHHHHHCCCCCCC | 7.37 | 17993265 | |
125 | Phosphorylation | YYNWGRFSKPPEDDD HHCCCCCCCCCCCCC | 42.78 | 23684312 | |
126 | Ubiquitination | YNWGRFSKPPEDDDA HCCCCCCCCCCCCCC | 62.98 | - | |
135 | Phosphorylation | PEDDDANSYENVLIC CCCCCCCCCCCEEEE | 35.23 | 23401153 | |
136 | Phosphorylation | EDDDANSYENVLICK CCCCCCCCCCEEEEE | 16.01 | 12486104 | |
145 | Ubiquitination | NVLICKQKTTETGAQ CEEEEEEECCCCCCC | 42.80 | 25015289 | |
165 | Phosphorylation | GLCRGDLSLSLALKT CCCCCCEEEEEEECC | 22.20 | 30266825 | |
167 | Phosphorylation | CRGDLSLSLALKTGP CCCCEEEEEEECCCC | 14.28 | 23401153 | |
175 | Phosphorylation | LALKTGPTSGLCPSA EEECCCCCCCCCCCC | 36.45 | 30108239 | |
176 | Phosphorylation | ALKTGPTSGLCPSAS EECCCCCCCCCCCCC | 32.66 | 30108239 | |
181 | Phosphorylation | PTSGLCPSASPEEDE CCCCCCCCCCCCCCC | 40.14 | 28450419 | |
183 | Phosphorylation | SGLCPSASPEEDEES CCCCCCCCCCCCCCC | 36.86 | 28450419 | |
190 | Phosphorylation | SPEEDEESEDYQNSA CCCCCCCCHHHCCHH | 33.45 | 23401153 | |
193 | Phosphorylation | EDEESEDYQNSASIH CCCCCHHHCCHHHHH | 12.92 | 12486104 | |
196 | Phosphorylation | ESEDYQNSASIHQWR CCHHHCCHHHHHHHH | 14.10 | 23401153 | |
198 | Phosphorylation | EDYQNSASIHQWRES HHHCCHHHHHHHHHH | 22.03 | 28450419 | |
205 | Phosphorylation | SIHQWRESRKVMGQL HHHHHHHHHHHHHHH | 28.91 | - | |
217 | Phosphorylation | GQLQREASPGPVGSP HHHHHHCCCCCCCCC | 26.15 | 22115753 | |
223 | Phosphorylation | ASPGPVGSPDEEDGE CCCCCCCCCCCCCCC | 29.43 | 29052541 | |
233 | Phosphorylation | EEDGEPDYVNGEVAA CCCCCCCCCCCEEEE | 13.41 | 12486104 | |
241 | Phosphorylation | VNGEVAATEA----- CCCEEEECCC----- | 23.78 | 22115753 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
95 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
110 | Y | Phosphorylation | Kinase | KIT | P10721 | PSP |
110 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
118 | Y | Phosphorylation | Kinase | KIT | P10721 | PSP |
118 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
119 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
136 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
136 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
193 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
233 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NTAL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NTAL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GRB2_HUMAN | GRB2 | physical | 12514734 | |
PLCG1_HUMAN | PLCG1 | physical | 12514734 | |
PLCG2_HUMAN | PLCG2 | physical | 12514734 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-135, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY. | |
"The importance of three membrane-distal tyrosines in the adaptorprotein NTAL/LAB."; Koonpaew S., Janssen E., Zhu M., Zhang W.; J. Biol. Chem. 279:11229-11235(2004). Cited for: MUTAGENESIS OF TYR-58; TYR-84; TYR-95; TYR-110; TYR-118; TYR-136;TYR-193 AND TYR-233, PHOSPHORYLATION AT TYR-136; TYR-193 AND TYR-233,AND INTERACTION WITH GRB2. | |
"Non-T cell activation linker (NTAL): a transmembrane adaptor proteininvolved in immunoreceptor signaling."; Brdicka T., Imrich M., Angelisova P., Brdickova N., Horvath O.,Spicka J., Hilgert I., Luskova P., Draber P., Novak P., Engels N.,Wienands J., Simeoni L., Oesterreicher J., Aguado E., Malissen M.,Schraven B., Horejsi V.; J. Exp. Med. 196:1617-1626(2002). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASSSPECTROMETRY, INTERACTION WITH GRB2; SOS1; GAB1 AND CBL, TISSUESPECIFICITY, PALMITOYLATION AT CYS-25 AND CYS-28, SUBCELLULARLOCATION, PHOSPHORYLATION AT TYR-136; TYR-193 AND TYR-233,UBIQUITINATION, AND FUNCTION. |